JADE - Clinical Research Platform on Treatment and Outcome in Patients With Hepatocellular or Cholangiocellular Cancer

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study with associated satellites, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma (CCC) in Germany.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Confirmed hepatocellular carcinoma (HCC) or cholangiocarcinoma (CCC) als early, intermediate or advanced/metastatic stage

• Age ≥ 18 years

• Signed and dated informed consent (IC):

‣ For participation in the PRO module: Before primary locoregional therapy or start of first systemic treatment

⁃ For no participation in the PRO module: No later than 8 weeks after primary locoregional therapy or start of first systemic treatment

Locations
Other Locations
Germany
Multiple sites all over germany
RECRUITING
Multiple Locations
Contact Information
Primary
iOMEDICO AG
info@iomedico.com
+49 761 15242-0
Time Frame
Start Date: 2020-08-09
Estimated Completion Date: 2027-12
Participants
Target number of participants: 1000
Treatments
Hepatocellular Carcinoma (HCC)
Patients with Hepatocellular Carcinoma (HCC)
Cholangiocarcinoma (CCC)
Patients with Cholangiocarcinoma (CCC)
Sponsors
Leads: iOMEDICO AG

This content was sourced from clinicaltrials.gov

Similar Clinical Trials